Gary C. Floyd, Chief Operating Officer

Gary Floyd headshotGary is a seasoned pharmaceutical executive with over 40 years’ experience in the manufacture, sales and development of drugs and biologicals.

Armour Pharmaceutical Company

Plant Manager and Vice President of Operations of their 500,000 sq. ft. manufacturing plant that produced Small Volume and Large Volume sterile liquids, plasma proteins, oral drugs and inhalation products using form-fill-seal technology. In addition, he was Vice President of Marketing and Sales at Armour for North and South America.


Senior Vice President of Global Operations for Centeon, a combined Plasma Products company of Armour Pharmaceutical Company and Behringwerke, AG.

Aventis Behring

Senior Vice President of Worldwide Logistics

Eximias Pharmaceuticals/YM Biosciences   

In 2004, he joined Eximias Pharmaceuticals as head of Clinical Operations, Manufacturing and Quality Control.  Eximias later merged with YM Biosciences where he was Vice President of Operations and led manufacturing development, Quality Assurance and Assay Development.

Cangene Corporation

Chief Operating Officer of Cangene Corporation from 2012 to 2014 where he was responsible for regulatory compliance, quality assurance, manufacturing, analytical testing and development, project management and government contracting. He also served as the Chief Compliance Officer for the company.

Gary has a bachelor degree in Zoology and Chemistry from Olivet Nazarene University and has attended continuing education programs including Finance at University of Pennsylvania, Strategic Marketing at both Stanford and Harvard University and a Pharmacy program at the University of Tennessee.

Professional Associations

Member, American Association of Pharmaceutical Scientists